Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-16FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
FDA approved a Supplemental Application for a generic oxycodone and acetaminophen product from SpecGx LLC under an ANDA.
-
FDA approval · 2016-12-16FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for a generic acetaminophen and codeine phosphate product (SpecGx LLC) under ANDA 040419, enabling m…
-
FDA approval · 2016-12-16FDA Approved: NALBUPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for nalbuphine hydrochloride from Hospira, Inc., authorizing a change to the product’s approval.
-
FDA approval · 2016-12-16FDA Approved: METHADOSE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for Methadose (methadone hydrochloride) filed by SpecGx LLC.
-
FDA approval · 2016-12-16FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for BUTRANS (buprenorphine) from Purdue Pharma LP. This constitutes an additional regulatory action …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-12-16FDA Approved: OXAYDO — Supplemental Application (Zyla Life Sciences US LLC)
FDA approved a supplemental application for OXAYDO (oxycodone hydrochloride) from Zyla Life Sciences US LLC.
-
FDA approval · 2016-12-16FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for Acetaminophen and Codeine Phosphate from Aurolife Pharma, LLC.
-
FDA approval · 2016-12-16FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for methadone hydrochloride submitted by Mylan Institutional LLC. The action may involve labelin…
-
FDA approval · 2016-12-16FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for buprenorphine hydrochloride from Advagen Pharma Ltd, representing an approved amendment to an ex…
-
FDA approval · 2016-12-16FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)
The FDA approved a supplemental application for XTAMPZA ER (oxycodone) from Collegium Pharmaceutical, Inc., to modify the product labeling u…
-
FDA approval · 2016-12-16FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for a pentazocine and naloxone combination product from Actavis Pharma, Inc.
-
FDA approval · 2016-12-16FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Acetaminophen and Codeine Phosphate manufactured by Strides Pharma Science Limited.
-
FDA approval · 2016-12-16FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for butorphanol tartrate filed by Hikma Pharmaceuticals USA Inc., updating the drug's labeling.
-
FDA approval · 2016-12-16FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)
The FDA approved a supplemental application for Belbuca (buprenorphine hydrochloride) submitted by BioDelivery Sciences International Inc.
-
FDA approval · 2016-12-16FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for oxycodone and acetaminophen from Aurolife Pharma, supporting continued marketing of the generic …
-
FDA approval · 2016-12-16FDA Approved: MORPHINE SULFATE — Supplemental Application (Fresenius Kabi, USA LLC)
FDA has approved a supplemental application for Morphine Sulfate submitted by Fresenius Kabi, USA LLC under NDA204223.
-
FDA approval · 2016-12-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride by Hikma Pharmaceuticals USA Inc., granting regulatory clearance for…
-
FDA approval · 2016-11-14FDA Approved: MORPHINE SULFATE — Original Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved Morphine Sulfate as an Original Application generic product (ANDA 206573) for PAI Holdings dba PAI Pharma.
-
FDA approval · 2016-11-04FDA Approved: FENTANYL SYSTEM — Original Application (ALVOGEN)
The FDA has approved ALVOGEN's FENTANYL SYSTEM as an original-application generic product.
-
FDA approval · 2016-11-02FDA Approved: UP AND UP IBUPROFEN PM — Supplemental Application (Target Corporation)
FDA approved a supplemental application for Target's Up and Up Ibuprofen PM, a diphenhydramine citrate and ibuprofen combination product int…
-
FDA approval · 2016-11-01FDA Approved: KETOROLAC TROMETHAMINE — Original Application (FOSUN PHARMA USA INC)
FDA approved the original application for a generic ketorolac tromethamine product from Fosun Pharma USA Inc, for short-term relief of moder…
-
FDA approval · 2016-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for Methadone Hydrochloride by VistaPharm, LLC, enabling the generic product to be marketed. This ac…
-
FDA approval · 2016-10-28FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride (SpecGx LLC), confirming continued approval and availability of this gen…
-
FDA approval · 2016-10-10FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ketorolac tromethamine from Sun Pharmaceutical Industries, Inc. This action confirms regulatory …
-
FDA approval · 2016-09-30FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc.